The male god of magic capital

Chapter 194 195 Shocks the Medical Sector!
The next day, April 4, Monday, the eve of the stock market opening.

Chengtian Holding Company, in the trading room.

"Boss, are we going to buy the bottom of the medical sector when the market opens?" Jiang Manman asked.

Luo Cheng: "No, first sell some stocks and then buy them."

The Chengtian public offering fund is now as high as 700 billion, holding stocks worth 450 billion, and the liquidity is as high as 250 billion, which can be described as terrifying!
If these 250 billion funds are invested in the medical sector, it is conceivable that the medical sector will rise in a weak position today.

But Luo Cheng had his plan to sell some stocks first, and then buy them again.

Especially in the future, Chengtian Private Equity Fund will buy Aier Ophthalmology's shares, and Chengtian Public Equity Fund has a lot of them, which can just be sold, and the stock price of Aier Ophthalmology will be dropped.

"One hour after the opening of the market, sell the five stocks of Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biological!"

"Yes, BOSS!" Everyone was very excited.

At present, Chengtian Public Fund holds 20 stocks in the medical sector, with a total value of 450 billion, and each stock holds 22.5 billion on average.

Selling the shares of these five companies is equivalent to selling 5 billion worth of shares in the market.

After the stock market opened, the market began to strengthen today, and stocks in the medical sector rose sharply.

Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biology are five stocks that have risen particularly fast. After all, they are leading stocks. The market is strengthening, and they are leading the charge.

In the 1-hour trend chart, there is a big positive line.

In particular, the stock price of Aier Ophthalmology has rushed to 28 yuan a share.

When the time came to 10:[-] a.m., Chengtian Public Fund began to sell.

Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biotech all turned around and fell.

"what happened?"

"What kind of plane does Aier Ophthalmology operate?"

"I'm going, why did Mao make a U-turn?"

"The profit in my account is going to disappear, I'm paralyzed, I just entered the market today!"

"WuXi AppTec's increase is almost gone."

"The market is strong today, why is Mindray Medical's share price falling?"

"Jiu'an Medical Group and Fuxing Medicine are all on the rise, why is the Hengrui Medicine I bought falling?"

"Hey, I can't understand it either. I don't understand why Zhifei Biological also fell. Isn't this rising well? Why did it suddenly fall?" A small retail investor felt baffled.

"Could it be that Chengtian Public Fund is selling on a large scale?"

"impossible!"

"Maybe Chengtian Public Fund is selling these five stocks and buying other stocks."

"I'll go, I'll sell Aier Ophthalmology as well."

"Sell WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biology. I feel that Chengtian Public Fund does not intend to hold these five stocks."

"Although the market is strong, it is likely to fall sharply in the next day. This Chengtian public offering fund must take the opportunity to cash out stocks."

"Paralyzed, I sold WuXi AppTec!"

"Minray Medical also sell some!"

"I dare not hold Hengrui Medicine anymore."

"Withdraw, withdraw, withdraw at a loss of 1 point, I sold the Zhifei creature!"

At the close of trading in the morning, the five stocks of Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biotech were sold off by Chengtian Public Fund, causing their stock prices to plummet from sharp rises. It is particularly conspicuous in the medical sector, and has attracted the attention of many public equity funds, private equity funds, and securities companies.

"What's going on in the medical sector?"

"I'll go, the stock price of Aier Ophthalmology has turned around and plummeted again."

"I still plan to buy WuXi AppTec, but forget it now."

"I hold a lot of Mindray Medical, it's better to sell it in the afternoon"

"Hengrui Medicine has also plummeted, it must be the Chengtian public offering fund that is selling!"

"This Chengtian public offering fund is selling the medical sector. My God, this must be pessimistic about the future market trend. Our fund has a lot of Zhifei Biotech stocks, which can be liquidated."

At this moment, the fund manager of Fang Yida Medical Hybrid Fund watched the stock price of Aier Ophthalmology go down all the way.

"This Chengtian Public Fund is selling!"

···
Chengtian Holding Company, Luo Cheng asked, "Is the sale over?"

Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biological, the five major medical giants, are all the stocks operated by Chengtian Private Equity Fund, and Guo Haixing said that the power of the Bund Trading Club intends to participate in WuXi Of the three giants, Kangde, Mindray Medical, and Hengrui Medicine, it is natural to lower their stock prices first, and Luo Cheng is naturally the first to let Chengtian Public Fund enter the market.

This time, Chengtian Public Fund sold the shares of Aier Ophthalmology, and also smashed its stock price, from a big rise to a big drop, in preparation for the next Chengtian Private Equity Fund to aggressively buy Aier Ophthalmology's stock.

"Boss, the sale has been completed." Jiang Manman asked: "Are we going to buy bottoms in the afternoon?"

Luo Cheng nodded: "If the market continues to strengthen in the afternoon, build positions slowly, and if the market weakens, buy more."

"Now the scale has reached 700 billion, and the position ratio should be kept at 90%. That is 630 billion, which is allocated to 30 stocks."

Jiang Manman asked: "Boss, we currently hold 15 stocks of Jiu'an Medical Group... Fuxing Pharmaceutical, Pien Tze Huang, Pharmaron, Changxin High-tech, and Asymchem. What about the remaining 15 stocks?"

Luo Cheng: "Buy Junshi Biotech, Hualan Biotech, China Resources Sanjiu, China Resources Double Crane, Tongrentang, Da'an Gene, Huahai Pharmaceuticals, Porton, Kelun Pharmaceuticals, Wantai Biologics, Medicilon at the opening of the afternoon. , Yunnan Baiyao, Dong'e Ejiao, Baiyun Mountain, CanSino."

Speaking of which, Luo Cheng wrote down these 15 stocks!
Soon after the market opened in the afternoon, the market weakened, and stock index futures were also shorted, which produced a linkage effect, and the entire stock market turned around and began to fall.

The stock prices of the medical sector have also fallen one after another, and the five stocks of Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biological have fallen even worse because they were sold by Chengtian Public Fund before.

"Paralyzed, this Chengtian public offering fund has been sold in advance."

"The stock market is bound to plummet in the next few days, and everyone will withdraw!"

"I'm going, the share price of Jiu'an Medical Group has turned around and plummeted, withdraw, withdraw, withdraw!"

"Chengtian Public Fund must have predicted the market!"

"I'll go, maybe Chengtian Public Fund is shorting the Shanghai and Shenzhen 300 Index futures to hedge!"

"The next stock market may continue to go bearish!"

"Everyone, sell your stocks and run away!"

····
And Chengtian Public Fund is about to start buying.

This time, we will allocate assets to 30 stocks in the medical sector, hold 630 billion stocks, and retain 70 billion in cash flow.

And for these 30 stocks, each stock is calculated to allocate 21 billion.

"Jiu'an Medical Group sold 2 million!"

"Jianfan Biology bought 1 million!"

"Opcon Vision sold 1.5 million!"

"Fosun Pharma sold 3 million!"

"Pen Tze Huang bought 2.5 million!"

"Pharmaceuticals bought 1.5 million!"

"Asymchem bought 1.5 million!"

"Tongce Medical bought 4 million!"

"Watson Bio sold 4 million!"

····
"Hualan Biotech bought 21 billion!
"China Resources Sanjiu and China Resources Double Crane both bought 21 billion!"

"Tongrentang, Da'an Gene, and Huahai Pharmaceutical bought 21 billion!"

"Botten, Nanbaiyao, Dong'e Ejiao, Baiyun Mountain, and CanSino all bought 21 billion!"

···
Immediately, the medical sector began to fluctuate again, and the falling stocks accelerated their decline, such as Jiu'an Medical Group.

Of course, stocks that fall may also rise, such as Tongce Medical.

Of course, there were 15 stocks that skyrocketed, because Chengtian Public Fund invested 21 billion in each stock, and such a large buying order directly drove the stock price soaring!

The price increases all exceeded 20%, and there were even daily limit boards. For example, China Resources Sanjiu, China Resources Double Crane, and Daan Gene were pulled to the daily limit board.

"My God, this stock price has gone up so much."

"The main force is crazy about sweeping goods!"

"Is this mud horse the Chengtian Public Fund?"

"Damn, this Chengtian public offering fund sells in the morning and sweeps in the afternoon?"

"I'm going, I don't understand."

"This China Resources Sanjiu, China Resources Double Crane, and Da'an Gene have changed from a big drop to a daily limit, which is too violent."

"During the morning session, Chengtian Public Fund was clearing Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, Zhifei Biological, and the afternoon session was sweeping!"

"Junshi Bio, Hualan Bio, China Resources Sanjiu... Baiyunshan, CanSino, these fifteen stocks have all risen amazingly, basically all rose by more than 20%, my God!"

"Sweeping is too aggressive!"

"Is Chengtian Public Fund entering the market?"

"It must be the Chengtian Public Fund that is sweeping the stock, I have already followed up!"

"Tomorrow, everyone, continue to buy!"

It was 3:[-] in the afternoon.

"Boss, all the funds have been invested in the medical sector."

"The allocation of 30 stocks is complete."

Luo Cheng nodded.

Time flies, the market did not continue to fall, China Resources Sanjiu, China Resources Double Crane, and Daan Gene did not explode, and the stock prices of the other 27 stocks also stabilized.

At 4:10 p.m., Chengtian Public Fund announced its net worth.

Unit Net Value: 1.9158 (+3%)

"Grandmother, I knew Chengtian Public Fund was doing a big sweeps!"

"The market is still down today, and I don't know if it will continue to fall tomorrow."

"Today, most of the stocks in the medical sector have been raised by Chengtian Public Fund."

"If the market strengthens tomorrow, the net value per unit of Chengtian Public Fund will definitely continue to increase!"

"That's not clear."

"I hope the market will strengthen tomorrow. I have bought the bottom of Mindray Pharmaceuticals!"

"Hell, I bought the bottom of Aier Ophthalmology, but I was caught. It will be fine if it goes up tomorrow."

"Today, Chengtian Public Fund has cleared Aier Ophthalmology, WuXi AppTec, Mindray Medical, Hengrui Medicine, and Zhifei Biotech. It means that the fundamentals of these five stocks have disappointed Chengtian Holdings."

"Wait for the trend of the market tomorrow!"

(End of this chapter)